|
Volumn 1, Issue 1, 2004, Pages 71-76
|
Anti-CD137 monoclonal antibody promotes the direct anti-tumor effect mediated by peripheral blood-derived human dendritic cells in vitro.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CD137 ANTIGEN;
CD137 LIGAND;
LEUKOCYTE ANTIGEN;
MONOCLONAL ANTIBODY;
NERVE GROWTH FACTOR RECEPTOR;
TNFRSF9 PROTEIN, HUMAN;
TNFRSF9 PROTEIN, MOUSE;
TNFSF9 PROTEIN, HUMAN;
TNFSF9 PROTEIN, MOUSE;
TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR RECEPTOR;
ARTICLE;
DENDRITIC CELL;
HUMAN;
IMMUNOLOGY;
METABOLISM;
TUMOR CELL LINE;
4-1BB LIGAND;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD;
ANTIGENS, CD137;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
DENDRITIC CELLS;
HUMANS;
RECEPTORS, NERVE GROWTH FACTOR;
RECEPTORS, TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTORS;
|
EID: 33644823583
PISSN: 16727681
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (0)
|